Abstract
Current treatment of malignant glioma brain tumors is unsatisfactory. Gene therapy has much promise, but target-specific vectors are needed. Endothelial progenitor cells (EPCs) have in vivo homing specificity to angiogenic sites and are thus potential vehicles for site-specific gene therapy. However, reports of EPCs ‘homing’ to intracranial solid tumors are lacking. We investigated EPCs’ ‘homing’ specificity using a murine intracranial glioma model. EPCs, derived from human cord blood, were labeled with a fluorogenic agent CFSE and intravenously injected into SCID mice bearing orthotopic gliomas. At 7–14 days after EPC injection, mouse brains and other vital organs were examined for distribution of transplanted EPCs. As controls, CFSE-labeled human umbilical vein endothelial cells (HUVECs) and EPCs were intravenously injected into matched glioma SCID mice (HUVEC control groups) and nontumor SCID mice (nontumor-bearing control groups), respectively. Fluorescence image analysis revealed that systemically transplanted EPCs ‘homed’ to brain tumors with significantly higher specificity as compared to other organs within the experimental group (P<0.001) and to anatomically matched brain sections from the control groups (P<0.001). Our study demonstrates EPCs’ in vivo tropism for intracranial gliomas, with potential for cell delivery of brain tumor spatial-specific gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gurney JG, Kadan-Lottick N . Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001; 13: 160–166.
Feldman AL, Libutti SK . Progress in antiangiogenic gene therapy of cancer. Cancer 2000; 89: 1181–1194.
Puduvalli VK, Sawaya R . Antiangiogenesis – therapeutic strategies and clinical implications for brain tumors. J Neurooncol 2000; 50: 189–200.
Hood JD et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296: 2404–2407.
Lyden D et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194–1201.
Asahara T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
Hatzopoulos AK et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development (Cambridge, England) 1998; 125: 1457–1468.
Levenberg S et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391–4396.
Nieda M et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 1997; 98: 775–777.
Murohara T et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527–1536.
Shintani S et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897–903.
Asahara T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (Online) 1999; 85: 221–228.
Kalka C et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422–3427.
Lin Y et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71–77.
Asahara T et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964–3972.
Hess DC et al. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke; a J Cereb Circ 2002; 33: 1362–1368.
Marchetti S et al. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J Cell Sci 2002; 115 (Part 10): 2075–2085.
Iwaguro H et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732–738.
Folkman J . Tumor angiogenesis. Adv Cancer Res 1985; 43: 175–203.
Brem S, Cotran R, Folkman J . Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972; 48: 347–356.
Reyes M et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337–346.
Ribatti D et al. Postnatal vasculogenesis. Mech Dev 2001; 100: 157–163.
Yancopoulos GD et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248.
St Croix B et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197–1202.
Ferrari N et al. Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Therapy 2003; 10: 647–656.
Scott SD et al. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Therapy 2000; 7: 1121–1125.
Motulsky HJ . Analyzing Data with GraphPad Prism. GraphPad Software, Inc., 1999.
Acknowledgements
We thank Ong Poh Chee and Ng Kian Chye for excellent technical support. This work was supported by the Stem Cell Research Group and the National Medical Research Council of Singapore.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, XL., Lu, J., Sun, L. et al. Endothelial progenitor cells’ ‘homing’ specificity to brain tumors. Gene Ther 11, 811–818 (2004). https://doi.org/10.1038/sj.gt.3302151
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302151
Keywords
This article is cited by
-
Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis
Arthritis Research & Therapy (2016)
-
A putative nitroreductase from the DosR regulon of Mycobacterium tuberculosis induces pro-inflammatory cytokine expression via TLR2 signaling pathway
Scientific Reports (2016)
-
Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis
Arthritis Research & Therapy (2014)
-
Endothelial progenitor cells homing to the orthotopic implanted liver tumor of nude mice
Journal of Huazhong University of Science and Technology [Medical Sciences] (2012)
-
AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study
BMC Biotechnology (2009)